Table 4.
Association of patient-reported symptoms (absence/presence) and survival after controlling for CD4 count and HIV-1 RNA, using Cox proportional regression
| Symptom | Hazard ratio | 95% Hazard ratio confidence limits |
|
|---|---|---|---|
| Fatigue/loss of energy | 1.29 | 0.87 | 1.90 |
| Fevers/chills/sweats | 0.90 | 0.64 | 1.26 |
| Dizzy/lightheadedness | 1.22 | 0.84 | 1.76 |
| Numbness/tingling in hands/feet | 0.89 | 0.64 | 1.23 |
| Trouble remembering | 0.95 | 0.69 | 1.32 |
| Nausea/vomiting | 1.13 | 0.79 | 1.63 |
| Diarrhea/loose bowels | 0.71 | 0.51 | 0.98 |
| Sad/depressed | 0.90 | 0.62 | 1.30 |
| Nervous/anxious | 0.93 | 0.64 | 1.35 |
| Difficulty sleeping | 1.00 | 0.71 | 1.41 |
| Skin problems/rash/itching | 1.01 | 0.74 | 1.39 |
| Coughing/trouble breathing | 1.00 | 0.71 | 1.40 |
| Headaches | 0.94 | 0.68 | 1.32 |
| Loss appetite/food taste | 1.35 | 0.94 | 1.93 |
| Bloating/pain/gas in stomach | 1.21 | 0.86 | 1.70 |
| Muscle aches/joint pains | 0.74 | 0.53 | 1.02 |
| Problems with sex | 1.04 | 0.76 | 1.43 |
| Change in body composition | 1.02 | 0.74 | 1.41 |
| Problems with weight loss/wasting | 1.28 | 0.93 | 1.77 |
| Hair loss or changes | 1.04 | 0.74 | 1.45 |
Note: Bold text indicates statistically significant result